Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis

Chunmei Cui, Hong Lu Department of Ophthalmology, Beijing Chao-Yang Hospital, Beijing, China Purpose: Conbercept is a new anti-vascular endothelial growth factor (VEGF) drug approved for the treatment of age-related macular degeneration (AMD). Although this novel drug has been widely used in clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cui C, Lu H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
AMD
CRT
Acceso en línea:https://doaj.org/article/07601f6b648f404a9b87832cfbc69e5b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!